CellsBin

CellsBin is a venture capital-backed startup located in New Haven, CT, specializing in advanced single-cell analysis using AI and photonics. The company was founded by industry veterans and experts in molecular biology, aiming to revolutionize cancer detection and treatment. CellsBin's core service involves identifying individual cells of interest among billions, which is crucial for early cancer diagnosis and personalized treatment plans. The business primarily serves the healthcare and research sectors, collaborating with prestigious institutions like MD Anderson and Johns Hopkins. CellsBin generates revenue through partnerships and collaborations with medical and research institutions, leveraging its cutting-edge technology to provide valuable insights into cancer treatment. The company's laboratory, situated near Yale University, acts as the central hub for its research and development activities.

Keywords: AI, single-cell analysis, cancer detection, photonics, molecular biology, healthcare, research, personalized treatment, New Haven, venture capital.